As a healthcare provider, I want to add some clinical context to this discussion on Has anyone dealt with month 2 and i have.
Building on what MarkLI_maint said β the evidence base here is well-established. The key publications to reference are from the STEP program[1].
Key clinical points:
- Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
- Side effect profile is predictable and usually manageable with standard protocols
- Monitoring should include baseline labs and follow-up at 3-month intervals
- Patient education significantly improves outcomes and adherence
Standard disclaimer: this is educational, not individualized medical advice.
References:
[1] See thread title for relevant study identification.
Last edited: Mar 19, 2025 at 5:51 PM